4.8 Article

Myristoylome Profiling Reveals a Concerted Mechanism of ARF GTPase Deacylation by the Bacterial Protease IpaJ

Journal

MOLECULAR CELL
Volume 58, Issue 1, Pages 110-122

Publisher

CELL PRESS
DOI: 10.1016/j.molcel.2015.01.040

Keywords

-

Funding

  1. NIH-NIGMS [R01GM087544]
  2. Starr Cancer Consortium [I7-A717]
  3. NIH-NIAID [NRSA F32 I-F32-AIO98384]
  4. National Institute of Health (NIAID) [RO1AI083359]
  5. National Institute of Health (NIGMS) [RO1GM100486]
  6. Welch Foundation [I-1704]
  7. Burroughs Wellcome Fund

Ask authors/readers for more resources

N-myristoylation is an essential fatty acid modification that governs the localization and activity of cell signaling enzymes, architectural proteins, and immune regulatory factors. Despite its importance in health and disease, there are currently no methods for reversing protein myristoylation in vivo. Recently, the Shigella flexneri protease IpaJ was found to cleave myristoylated glycine of eukaryotic proteins, yet the discriminatory mechanisms of substrate selection required for targeted demyristoylation have not yet been evaluated. Here, we performed global myristoylome profiling of cells treated with IpaJ under distinct physiological conditions. The protease is highly promiscuous among diverse N-myristoylated proteins in vitro but is remarkably specific to Golgi-associated ARF/ARL family GTPases during Shigella infection. Reconstitution studies revealed a mechanistic framework for substrate discrimination based on IpaJ's function as a GTPase effector'' of bacterial origin. We now propose a concerted model for IpaJ function that highlights its potential for programmable demyristoylation in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available